{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:45:10Z","timestamp":1785282310247,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangdong Pharmaceutical Association","award":["2023QNTJ45"],"award-info":[{"award-number":["2023QNTJ45"]}]},{"name":"Lianyungang Huilan Public Welfare Foundation","award":["HLJJ202209029"],"award-info":[{"award-number":["HLJJ202209029"]}]},{"name":"Guangdong Province Clinical Drug Research Fund project","award":["2022JZ21"],"award-info":[{"award-number":["2022JZ21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01174-3","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T06:52:58Z","timestamp":1744267978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulatory T Cell Infiltration-Driven Single-Cell Transcriptomic Analysis Identifies SAP18 as a Prognostic Marker for Esophageal Squamous Cell Carcinoma"],"prefix":"10.1007","volume":"56","author":[{"given":"Jianxiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"3","key":"1174_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-a Cancer Journal for Clinicians. 2021;71(3):209\u201349.","journal-title":"Ca-a Cancer Journal for Clinicians"},{"issue":"1","key":"1174_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.20892\/j.issn.2095-3941.2016.0093","volume":"14","author":"H Liang","year":"2017","unstructured":"Liang H, Fan JH, Qiao YL. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med. 2017;14(1):33\u201341.","journal-title":"Cancer Biol Med"},{"issue":"3","key":"1174_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ccell.2022.02.007","volume":"40","author":"ZX Wang","year":"2022","unstructured":"Wang ZX, Cui C, Yao J, Zhang Y, Li M, Feng J, Yang S, Fan Y, Shi J, Zhang X, Shen L. Toripalimab plus chemotherapy in treatment-na\u00efve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial. Cancer Cell. 2022;40(3):277\u201388.","journal-title":"Cancer Cell"},{"issue":"10","key":"1174_CR4","first-page":"2345","volume":"6","author":"Y Liu","year":"2016","unstructured":"Liu Y, Ren Z, Yuan L, Xu S, Yao Z, Qiao L, Li K. Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer. Am J Cancer Res. 2016;6(10):2345.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"1174_CR5","doi-asserted-by":"publisher","first-page":"13897","DOI":"10.1038\/ncomms13897","volume":"8","author":"J Zhou","year":"2017","unstructured":"Zhou J, Wu Z, Wong G, Pectasides E, Nagaraja A, Stachler M, Zhang H, Chen T, Zhang H, Liu JB, Xu X. CDK4\/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma. Nature Commun. 2017;8(1):13897.","journal-title":"Nature Commun"},{"issue":"11","key":"1174_CR6","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/nm.3388","volume":"19","author":"CR Chong","year":"2013","unstructured":"Chong CR, J\u00e4nne PA. The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat Med. 2013;19(11):1389\u2013400.","journal-title":"Nat Med"},{"issue":"3","key":"1174_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2022.02.009","volume":"40","author":"S Yamamoto","year":"2022","unstructured":"Yamamoto S, Kato K. JUPITER-06 establishes immune checkpoint inhibitors as essential first-line drugs for the treatment of advanced esophageal squamous cell carcinoma. Cancer Cell. 2022;40(3):238\u201340.","journal-title":"Cancer Cell"},{"issue":"11","key":"1174_CR8","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.ccell.2023.09.011","volume":"41","author":"Z Liu","year":"2023","unstructured":"Liu Z, Zhang Y, Ma N, Yang Y, Ma Y, Wang F, Wang Y, Wei J, Chen H, Tartarone A, Velotta JB. Progenitor-like exhausted SPRY1+ CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma. Cancer Cell. 2023;41(11):1852\u201370.","journal-title":"Cancer Cell"},{"issue":"18","key":"1174_CR9","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.20.03614","volume":"39","author":"BM Eyck","year":"2021","unstructured":"Eyck BM, van Lanschot JJ, Hulshof MC, van der Wilk BJ, Shapiro J, van Hagen P, van Berge Henegouwen MI, Wijnhoven BP, van Laarhoven HW, Nieuwenhuijzen GA, Hospers GA. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol. 2021;39(18):1995\u20132004.","journal-title":"J Clin Oncol"},{"key":"1174_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejca.2020.08.002","volume":"138","author":"SL Liu","year":"2020","unstructured":"Liu SL, Wen J, Yang H, Li QQ, Chen YP, Zhu CC, et al. Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010. Eur J Cancer. 2020;138:113\u201321.","journal-title":"Eur J Cancer"},{"issue":"3","key":"1174_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"issue":"11","key":"1174_CR12","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.trecan.2023.07.015","volume":"9","author":"JH Kang","year":"2023","unstructured":"Kang JH, Zappasodi R. Modulating Treg stability to improve cancer immunotherapy. Trends in Cancer. 2023;9(11):911\u201327.","journal-title":"Trends in Cancer"},{"issue":"5","key":"1174_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s43018-023-00547-6","volume":"4","author":"L van Hooren","year":"2023","unstructured":"van Hooren L, Handgraaf SM, Kloosterman DJ, Karimi E, van Mil LW, Gassama AA, Solsona BG, de Groot MH, Brandsma D, Quail DF, Walsh LA. CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma. Nature Cancer. 2023;4(5):665\u201381.","journal-title":"Nature Cancer"},{"issue":"6","key":"1174_CR14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41590-023-01504-2","volume":"24","author":"A Glasner","year":"2023","unstructured":"Glasner A, Rose SA, Sharma R, Gudjonson H, Chu T, Green JA, Rampersaud S, Valdez IK, Andretta ES, Dhillon BS, Schizas M. Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies. Nat Immunol. 2023;24(6):1020\u201335.","journal-title":"Nat Immunol"},{"key":"1174_CR15","doi-asserted-by":"publisher","unstructured":"van Gulijk M, van Krimpen A, Schetters S, Eterman M, van Elsas M, Mankor J, Klaase L, de Bruijn M, van Nimwegen M, van Tienhoven T, van Ijcken W. PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Science Immunology. 2023 May 19;8(83):eabn6173. https:\/\/doi.org\/10.1126\/sciimmunol.abn6173","DOI":"10.1126\/sciimmunol.abn6173"},{"issue":"4","key":"1174_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41571-020-00449-x","volume":"18","author":"SH Gohil","year":"2021","unstructured":"Gohil SH, Iorgulescu JB, Braun DA, Keskin DB, Livak KJ. Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy. Nat Rev Clin Oncol. 2021;18(4):244\u201356.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1174_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-immunol-110519-071134","volume":"39","author":"X Ren","year":"2021","unstructured":"Ren X, Zhang L, Zhang Y, Li Z, Siemers N, Zhang Z. Insights gained from single-cell analysis of immune cells in the tumor microenvironment. Annual Review Immun. 2021;39(1):583\u2013609.","journal-title":"Annual Review Immun"},{"issue":"5","key":"1174_CR18","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","volume":"27","author":"A Bassez","year":"2021","unstructured":"Bassez A, Vos H, Van Dyck L, Floris G, Arijs I, Desmedt C, Boeckx B, VandenBempt M, Nevelsteen I, Lambein K, Punie K. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nature Med. 2021;27(5):820\u201332.","journal-title":"Nature Med"},{"issue":"1","key":"1174_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41591-019-0694-x","volume":"26","author":"S Goswami","year":"2020","unstructured":"Goswami S, Walle T, Cornish AE, Basu S, Anandhan S, Fernandez I, Vence L, Blando J, Zhao H, Yadav SS, Ott M. Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma. Nature Med. 2020;26(1):39\u201346.","journal-title":"Nature Med"},{"issue":"1","key":"1174_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/cai2.9","volume":"1","author":"N Hong","year":"2022","unstructured":"Hong N, Sun G, Zuo X, Chen M, Liu L, Wang J, et al. Application of informatics in cancer research and clinical practice: opportunities and challenges. Cancer Innov. 2022;1(1):80\u201391.","journal-title":"Cancer Innov"},{"issue":"9\u201310","key":"1174_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.drudis.2011.03.002","volume":"16","author":"NS Buchan","year":"2011","unstructured":"Buchan NS, Rajpal DK, Webster Y, Alatorre C, Gudivada RC, Zheng CY, et al. The role of translational bioinformatics in drug discovery. Drug Discovery Today. 2011;16(9\u201310):426\u201334.","journal-title":"Drug Discovery Today"},{"issue":"12","key":"1174_CR22","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1158\/1078-0432.CCR-19-1744","volume":"26","author":"F Xie","year":"2020","unstructured":"Xie F, Zhang JJ, Wang JY, Reuben A, Xu W, Yi X, et al. Multifactorial deep learning reveals pan-cancer genomic tumor clusters with distinct immunogenomic landscape and response to immunotherapy. Clin Cancer Res. 2020;26(12):2908\u201320.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1174_CR23","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/cbf.3830","volume":"41","author":"S Kumari","year":"2023","unstructured":"Kumari S, Rehman A, Chandra P, Singh KK. Functional role of SAP18 protein: from transcriptional repression to splicing regulation. Cell Biochem Funct. 2023;41(7):738\u201351.","journal-title":"Cell Biochem Funct"},{"issue":"8","key":"1174_CR24","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.bbadis.2018.05.013","volume":"1864","author":"C Wu","year":"2018","unstructured":"Wu C, Li JJ, Tian CC, Shi W, Jiang HM, Zhang Z, et al. Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis. BBA-Mol Basis Dis. 2018;1864(8):2511\u201325.","journal-title":"BBA-Mol Basis Dis"},{"issue":"156","key":"1174_CR25","doi-asserted-by":"publisher","first-page":"113887","DOI":"10.1016\/j.biopha.2022.113887","volume":"1","author":"KM Varier","year":"2022","unstructured":"Varier KM, Dan G, Liu W, Wu G, Xiao C, Lei H, Ling T, Jiang Y, Chen Y, Ben-David Y, Li Y. Stilbene B10 induces apoptosis and tumor suppression in lymphoid Raji cells by BTK-mediated regulation of the KRAS\/HDAC1\/EP300\/PEBP1 axis. Biomed Pharmacother. 2022;1(156):113887.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1174_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s42003-020-0817-4","volume":"3","author":"L Palanikumar","year":"2020","unstructured":"Palanikumar L, Al-Hosani S, Kalmouni M, Nguyen VP, Ali L, Pasricha R, Barrera FN, Magzoub M. pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics. Commun Biol. 2020;3(1):95.","journal-title":"Commun Biol"},{"issue":"13","key":"1174_CR27","doi-asserted-by":"publisher","first-page":"930921","DOI":"10.3389\/fimmu.2022.930921","volume":"24","author":"J Wang","year":"2022","unstructured":"Wang J, Huang F, Zhao J, Huang P, Tan J, Huang M, Ma R, Xiao Y, He S, Wang Z, Shen J. Tumor-infiltrated CD8+ T Cell 10-gene signature related to clear cell renal cell carcinoma prognosis. Frontiers Immun. 2022;24(13):930921.","journal-title":"Frontiers Immun"},{"issue":"8","key":"1174_CR28","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41419-019-1837-1","volume":"10","author":"X Han","year":"2019","unstructured":"Han X, Shi H, Sun Y, Shang C, Luan T, Wang D, Ba X, Zeng X. CXCR2 expression on granulocyte and macrophage progenitors under tumor conditions contributes to mo-MDSC generation via SAP18\/ERK\/STAT3. Cell Death Dis. 2019;10(8):598.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1174_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"key":"1174_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-020-00187-3","volume":"8","author":"R Huang","year":"2020","unstructured":"Huang R, Zhou L, Chi Y, Wu H, Shi L. LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer. Biomarker Res. 2020;8:1\u20136.","journal-title":"Biomarker Res"},{"key":"1174_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1\u201321.","journal-title":"Genome Biol"},{"issue":"7","key":"1174_CR32","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu DI, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"1174_CR33","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"issue":"1","key":"1174_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"issue":"11","key":"1174_CR35","doi-asserted-by":"publisher","first-page":"e22620","DOI":"10.1096\/fj.202200898R","volume":"36","author":"K Shi","year":"2022","unstructured":"Shi K, Li Y, Yang L, Zhang Z, Guo D, Zhang J, Lu Y. Profiling transcriptional heterogeneity of epithelium, fibroblasts, and immune cells in esophageal squamous cell carcinoma by single-cell RNA sequencing. The FASEB J. 2022;36(11):e22620.","journal-title":"The FASEB J"},{"issue":"7","key":"1174_CR36","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, Hao Y, Stoeckius M, Smibert P, Satija R. Comprehensive integration of single-cell data. Cell. 2019;177(7):1888\u2013902.","journal-title":"Cell"},{"issue":"D1","key":"1174_CR37","doi-asserted-by":"publisher","first-page":"D721","DOI":"10.1093\/nar\/gky900","volume":"47","author":"XX Zhang","year":"2019","unstructured":"Zhang XX, Lan YJ, Xu JY, Quan F, Zhao EJ, Deng CY, et al. Cell Marker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47(D1):D721\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1174_CR38","doi-asserted-by":"publisher","first-page":"7335","DOI":"10.1038\/s41467-021-27599-5","volume":"12","author":"HQ Dinh","year":"2021","unstructured":"Dinh HQ, Pan F, Wang G, Huang QF, Olingy CE, Wu ZY, Wang SH, Xu X, Xu XE, He JZ, Yang Q. Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment. Nature Commun. 2021;12(1):7335.","journal-title":"Nature Commun"},{"issue":"1","key":"1174_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41392-022-00946-8","volume":"7","author":"X Pan","year":"2022","unstructured":"Pan X, Wang J, Guo L, Na F, Du J, Chen X, Zhong A, Zhao L, Zhang L, Zhang M, Wan X. Identifying a confused cell identity for esophageal squamous cell carcinoma. Signal Transduct Target Ther. 2022;7(1):122.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1174_CR40","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H, Wang L, Lu T, Zhang Y, Sun Z, Han X. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nature Commun. 2022;13(1):816.","journal-title":"Nature Commun"},{"key":"1174_CR41","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Briefings in bioinformatics. 2021 Nov;22(6):bbab260.","DOI":"10.1093\/bib\/bbab260"},{"issue":"1","key":"1174_CR42","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V, Shen H, Laird PW, Levine DA, Carter SL. Inferring tumour purity and stromal and immune cell admixture from expression data. Nature Commun. 2013;4(1):2612.","journal-title":"Nature Commun"},{"issue":"10","key":"1174_CR43","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, Liu J. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nature Med. 2018;24(10):1550\u20138.","journal-title":"Nature Med"},{"issue":"3","key":"1174_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Hill A, Packer J, Lin D, Ma YA, Trapnell C. Single-cell mRNA quantification and differential analysis with Census. Nat Methods. 2017;14(3):309\u201315.","journal-title":"Nat Methods"},{"issue":"1","key":"1174_CR45","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using Cell Chat. Nature Commun. 2021;12(1):1088.","journal-title":"Nature Commun"},{"issue":"9","key":"1174_CR46","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s10552-012-0026-7","volume":"23","author":"ML Kwan","year":"2012","unstructured":"Kwan ML, Haque R, Lee VS, Chung WLJ, Avila CC, Clancy HA, et al. Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes Control. 2012;23(9):1587\u201391.","journal-title":"Cancer Causes Control"},{"issue":"27","key":"1174_CR47","doi-asserted-by":"publisher","first-page":"632531","DOI":"10.3389\/pore.2021.632531","volume":"9","author":"X Wang","year":"2021","unstructured":"Wang X, Liu Y, Leng X, Cao K, Sun W, Zhu J, Ma J. UBE2T contributes to the prognosis of esophageal squamous cell carcinoma. Pathol Oncol Res. 2021;9(27):632531.","journal-title":"Pathol Oncol Res"},{"issue":"12","key":"1174_CR48","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"2","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, Zhou R, Qiu W, Huang N, Sun L, Li X. IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Frontiers Immunol. 2021;2(12):687975.","journal-title":"Frontiers Immunol"},{"issue":"12","key":"1174_CR49","doi-asserted-by":"publisher","first-page":"702726","DOI":"10.3389\/fimmu.2021.702726","volume":"10","author":"EN Scott","year":"2021","unstructured":"Scott EN, Gocher AM, Workman CJ, Vignali DA. Regulatory T cells: barriers of immune infiltration into the tumor microenvironment. Frontiers Immunol. 2021;10(12):702726.","journal-title":"Frontiers Immunol"},{"issue":"8","key":"1174_CR50","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.ccell.2024.06.014","volume":"42","author":"S You","year":"2024","unstructured":"You S, Li S, Zeng L, Song J, Li Z, Li W, Ni H, Xiao X, Deng W, Li H, Lin W. Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity. Cancer Cell. 2024;42(8):1415\u201333.","journal-title":"Cancer Cell"},{"key":"1174_CR51","first-page":"104","volume":"1","author":"L Liu","year":"2024","unstructured":"Liu L, Xu L, Wu D, Zhu Y, Li X, Xu C, Chen K, Lin Y, Lao J, Cai P, Li X. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer. EBioMedicine. 2024;1:104.","journal-title":"EBioMedicine"},{"key":"1174_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1085-0","volume":"19","author":"C Li","year":"2020","unstructured":"Li C, Jiang P, Wei S, Xu X, Wang J. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Molecul Cancer. 2020;19:1\u201323.","journal-title":"Molecul Cancer"},{"key":"1174_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0556-6","volume":"7","author":"DE Kuczek","year":"2019","unstructured":"Kuczek DE, Larsen AM, Thorseth ML, Carretta M, Kalvisa A, Siersb\u00e6k MS, Sim\u00f5es AM, Roslind A, Engelholm LH, Noessner E, Donia M. Collagen density regulates the activity of tumor-infiltrating T cells. J Immunother Cancer. 2019;7:1\u20135.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"1174_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0092-8674(00)80216-0","volume":"89","author":"Y Zhang","year":"1997","unstructured":"Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P, Reinberg D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell. 1997;89(3):357\u201364.","journal-title":"Cell"},{"issue":"10","key":"1174_CR55","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41418-018-0268-3","volume":"26","author":"XY Ding","year":"2019","unstructured":"Ding XY, Xu JY, Wang C, Feng Q, Wang QX, Yang Y, et al. Suppression of the SAP18\/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65\/ReIA, NF-\u03baB activation, and promotion of cell invasion and angiogenesis. Cell Death Differ. 2019;26(10):1970\u201386.","journal-title":"Cell Death Differ"},{"issue":"1","key":"1174_CR56","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4161\/15384047.2014.987070","volume":"16","author":"L Farhana","year":"2015","unstructured":"Farhana L, Dawson MI, Fontana JA. Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells. Cancer Biol Ther. 2015;16(1):115\u201324.","journal-title":"Cancer Biol Ther"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01174-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:07:49Z","timestamp":1744272469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01174-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01174-3","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"11 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed based on the Declaration of Helsinki and approved by the Ethics Committee of the Guangzhou Red Cross Hospital, Jinan University (2022\u2013197-02, 16 January 2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors read and approved the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"97"}}